High-risk enteric pathogens associated with HIV infection and HIV exposure in Kenyan children with acute diarrhea

AIDS

Volumn 28, Issue 15, 2014, Pages 2287-2296

  Pavlinac, Patricia B ^a   John Stewart, Grace C ^a,b   Naulikha, Jaqueline M ^a,b   Onchiri, Frankline M ^a   Denno, Donna M ^a,b   Odundo, Elizabeth A ^c   Singa, Benson O ^a   Richardson, Barbra A ^a,d   Walson, Judd L ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^d WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

Africa; Cryptosporidium; Diarrhoea; Enteropathogenic escherichia coli; Hiv; Paediatrics

Indexed keywords

COTRIMOXAZOLE;

ACUTE DIARRHEA; ADOLESCENT; AMEBIASIS; ANTHROPOMETRIC PARAMETERS; ARTICLE; ASCARIASIS; ASCARIS LUMBRICOIDES; BACTERIUM CULTURE; BLASTOCYSTIS HOMINIS; BLASTOCYSTOSIS; BREAST FEEDING; CAMPYLOBACTER; CHILD; CHILDHOOD DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CROWDING (AREA); CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM; DIARRHEAGENIC ESCHERICHIA COLI; DISEASE ASSOCIATION; ENTEROAGGREGATIVE ESCHERICHIA COLI; ENTEROBACTERIACEAE; ENTEROPATHOGENIC ESCHERICHIA COLI INFECTION; ENVIRONMENTAL EXPOSURE; FECES ANALYSIS; FEMALE; GIARDIA; GIARDIA INTESTINALIS; GIARDIASIS; HEALTH STATUS; HIGH RISK PATIENT; HOUSEHOLD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCOME; INFANT; INFECTION RISK; KENYAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MICROSCOPY; OOCYTE; PARASITE PREVALENCE; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; WATER SUPPLY; WATER TREATMENT; ANIMAL; BACTERIAL INFECTIONS; CLASSIFICATION; COMPLICATION; DIARRHEA; FECES; INTESTINAL DISEASES, PARASITIC; ISOLATION AND PURIFICATION; KENYA; MICROBIOLOGY; PARASITE; PARASITOLOGY; PREVALENCE;

ADOLESCENT; ANIMALS; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DIARRHEA; ENTEROBACTERIACEAE; FECES; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INTESTINAL DISEASES, PARASITIC; KENYA; MALE; PARASITES; PREVALENCE;

EID: 84927910557     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000396     Document Type: Article

References (55)

1. Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, et al. Global, regional, and national causes of child mortality: An updated systematic analysis for 2010 with time trends since 2000. Lancet 2012; 379:2151-2161.
2. Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): A prospective, case-control study. Lancet 2013; 382:209-222.
3. Moore SR, Lima NL, Soares AM, Oria RB, Pinkerton RC, Barrett LJ, et al. Prolonged episodes of acute diarrhea reduce growth and increase risk of persistent diarrhea in children. Gastroenterology 2010; 139:1156-1164.
4. Lorntz B, Soares AM, Moore SR, Pinkerton R, Gansneder B, Bovbjerg VE, et al. Early childhood diarrhea predicts impaired school performance. Pediatr Infect Dis J 2006; 25:513-520.
5. Lunn PG, Northrop-Clewes CA, Downes RM. Intestinal permeability, mucosal injury, and growth faltering in Gambian infants. Lancet 1991; 338:907-910.
6. Prendergast A, Kelly P. Enteropathies in the developing world: neglected effects on global health. Am J Trop Med Hygiene 2012; 86:756-763.
7. Keusch GT, Rosenberg IH, Denno DM, Duggan C, Guerrant RL, Lavery JV, et al. Implications of acquired environmental enteric dysfunction for growth and stunting in infants and children living in low- And middle-income countries. Food Nutr Bull 2013; 34:357-364.
8. van Eijk AM, Brooks JT, Adcock PM, Garrett V, Eberhard M, Rosen DH, et al. Diarrhea in children less than two years of age with known HIV status in Kisumu, Kenya. Int J Infect Dis 2010; 14:e220-e225.
9. Thea DM, St Louis ME, Atido U, Kanjinga K, Kembo B, Matondo M, et al. A prospective study of diarrhea and HIV-1 infection among 429 Zairian infants.N Engl J Med 1993; 329:1696-1702.
10. Laughton B, Cornell M, Boivin M, Van Rie A. Neurodevelopment in perinatally HIV-infected children: A concern for adolescence. J Int AIDS Soc 2013; 16:18603.
11. Smith R, Chernoff M, Williams PL, Malee KM, Sirois PA, Kammerer B, et al. Impact of HIV severity on cognitive and adaptive functioning during childhood and a dolescence. Pediatr Infect Dis J 2012; 31:592-598.
12. Rollins NC, Ndirangu J, Bland RM, Coutsoudis A, Coovadia HM, Newell ML. Exclusive breastfeeding, diarrhoeal morbidity and all-cause mortality in infants of HIV-infected and HIV uninfected mothers: An intervention cohort study in KwaZulu Natal, South Africa. PLoS One 2013; 8:e81307.
13. World Health Organization. Global Report: UNAIDS report on the global AIDS epidemic 2013. Geneva, Switzerland: WHO; 2013.
14. Koyanagi A, Humphrey JH, Ntozini R, Nathoo K, Moulton LH, Iliff P, et al. Morbidity among human immunodeficiency virusexposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy. Pediatr Infect Dis J 2011; 30:45-51.
15. Le Doare K, Bland R, Newell ML. Neurodevelopment in children born to HIV-infected mothers by infection and treatment status. Pediatrics 2012; 130:e1326-e1344.
16. Slogrove A, Reikie B, Naidoo S, De Beer C, Ho K, Cotton M, et al. HIV-exposed uninfected infants are at increased risk for severe infections in the first year of life. J Trop Pediatr 2012; 58:505-508.
17. Filteau S. The HIV-exposed, uninfected African child. Trop Med Int Health 2009; 14:276-287.
18. Clerici M, Saresella M, Colombo F, Fossati S, Sala N, Bricalli D, et al. T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood 2000; 96:3866-3871.
19. Kasahara TM, Hygino J, Blanco B, Xavier L, Araujo-Lima CF, Guillermo LV, et al. The impact of maternal antiretroviral therapy on cytokine profile in the uninfected neonates. Hum Immunol 2013; 74:1051-1056.
20. World Health Organization. Handbook: Integrated management of childhood illness for high HIV settings. Geneva, Switzerland: WHO; 2008.
21. World Health Organization. WHO recommendations on the management of diarrhoea and pneumonia in HIV-infected infants and children. Geneva, Switzerland: WHO; 2010.
22. World Health Organization. The treatment of diarrhoea. A manual for physicians and other senior health workers. Geneva, Switzerland: WHO; 2007.
23. WHO Multicentre Growth Reference Study Group. WHOchild growth standards: length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-forage: Methods and development. Geneva: World Health Organization; 2006. pp. 312. http://www.who.int/childgrowth/publications/technical-report-2/en/[Accessed 9 September 2013].
24. de Onis M, Onyango A, Borghi E, Siyam A, Nishida C, Siekmann J. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Org 2007; 85:661- 668.
25. Aranda KR, Fabbricotti SH, Fagundes-Neto U, Scaletsky IC. Single multiplex assay to identify simultaneously enteropathogenic, enteroaggregative, enterotoxigenic, enteroinvasive and Shiga toxin-producing Escherichia coli strains in Brazilian children. FEMS Microbiol Lett 2007; 267:145-150.
26. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Ser B 1995; 57:289-300.
27. Goga AE, Doherty T, Jackson DJ, Sanders D, Colvin M, Chopra M, et al. Infant feeding practices at routine PMTCT sites, South Africa: results of a prospective observational study amongst HIV exposed and unexposed infants - birth to 9 months. Int Breastfeed J 2012; 7:4.
28. Isanaka S, Duggan C, Fawzi WW. Patterns of postnatal growth in HIV-infected and HIV-exposed children. Nutr Rev 2009; 67:343-359.
29. World Health Organization (WHO). Guidelines on co-trimoxazole prophylaxis for HIV-related infections among children, adolescents and adults: recommendations for a public health approach. Geneva: WHO Department of HIV/AIDS; 2006. http://www.who.int/entity/hiv/pub/guidelines/ctxguidelines.pdf [Accessed 26 July 2013].
30. Sherry B, Embree JE, Mei Z, Ndinya-Achola JO, Njenga S, Muchunga ER, et al. Sociodemographic characteristics, care, feeding practices, and growth of cohorts of children born to HIV-1 seropositive and seronegative mothers in Nairobi, Kenya. Trop Med Int Health 2000; 5:678-686.
31. World Health Organization. Antiretroviral therapy of HIV infection in infants and children: Towards universal access. Recommendations for a publich health approach. Geneva, Switzerland: WHO; 2006.
32. Stockmann M, Schmitz H, Fromm M, Schmidt W, Pauli G, Scholz P, et al. Mechanisms of epithelial barrier impairment in HIV infection. Ann N Y Acad Sci 2000; 915:293-303.
33. Trabulsi LR, Keller R, Tardelli Gomes TA. Typical and atypical enteropathogenic Escherichia coli. Emerg Infect Dis 2002; 8:508-513.
34. Kenya Ministry of Public Health Sanitation. Policy guidelines on control and management of diarrhoeal diseases in children below five years in Kenya. Nairobi, Kenya: Division of Child and Adolescent Health; 2010.
35. O'Ryan GM, Ashkenazi-Hoffnung L, O'Ryan-Soriano MA, Ashkenazi S. Management of acute infectious diarrhea for children living in resource-limited settings. Expert Rev Anti Infect Ther 2014; 12:621-632.
36. O'Reilly CE, Moke F, Ondeng A, Hukumu E, Ibworo V, Rajasingham A, et al. Moderate-to-severe diarrhea among children less than five years old with HIV infected mothers in rural western Kenya. The American Society of Tropical Medicine and Hygiene Annual Meeting; December 4-8 2011, Philadelphia, PA.
37. Hunter PR, Nichols G. Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin Microbiol Rev 2002; 15:145-154.
38. Ajjampur SS, Sankaran P, Kang G. Cryptosporidium species in HIV-infected individuals in India: An overview. Natl Med J India 2008; 21:178-184.
39. Korpe PS, Liu Y, Siddique A, Kabir M, Ralston K, Ma JZ, et al. Breast milk parasite-specific antibodies and protection from amebiasis and cryptosporidiosis in Bangladeshi infants: A prospective cohort study. Clin Infect Dis 2013; 56:988-992.
40. Guerrant DI, Moore SR, Lima AA, Patrick PD, Schorling JB, Guerrant RL. Association of early childhood diarrhea and cryptosporidiosis with impaired physical fitness and cognitive function four-seven years later in a poor urban community in northeast Brazil. Am J Trop Med Hygiene 1999; 61:707-713.
41. Mor SM, Tzipori S. Cryptosporidiosis in children in Sub- Saharan Africa: A lingering challenge. Clin Infect Dis 2008; 47:915-921.
42. Checkley W, Epstein LD, Gilman RH, Black RE, Cabrera L, Sterling CR. Effects of Cryptosporidium parvum infection in Peruvian children: growth faltering and subsequent catch-up growth. Am J Epidemiol 1998; 148:497-506.
43. Cabada MM, White AC Jr. Treatment of cryptosporidiosis: do we know what we think we know? Curr Opin Infect Dis 2010; 23:494-499.
44. Bailey JM, Erramouspe J. Nitazoxanide treatment for giardiasis and cryptosporidiosis in children. Ann Pharmacother 2004; 38:634-640.
45. Zardi EM, Picardi A, Afeltra A. Treatment of cryptosporidiosis in immunocompromised hosts. Chemotherapy 2005; 51:193- 196.
46. Lee G, Pan W, Penataro Yori P, Paredes Olortegui M, Tilley D, Gregory M, et al. Symptomatic and asymptomatic Campylobacter infections associated with reduced growth in Peruvian children. PLoS Negl Trop Dis 2013; 7:e2036.
47. Platts-Mills JA, Gratz J, Mduma E, Svensen E, Amour C, Liu J, et al. Association between stool enteropathogen quantity and disease in Tanzanian children using TaqMan array cards: A nested case-control study. Am J Trop Med Hygiene 2014; 90:133-138.
48. Muhsen K, Levine MM. A systematic review and meta-analysis of the association between Giardia lamblia and endemic pediatric diarrhea in developing countries. Clin Infect Dis 2012; 55 (Suppl 4):S271-S293.
49. Al-Mekhlafi HM, Al-Maktari MT, Jani R, Ahmed A, Anuar TS, Moktar N, et al. Burden of Giardia duodenalis infection and its adverse effects on growth of schoolchildren in rural Malaysia. PLoS Neglect Trop Dis 2013; 7:e2516.
50. Atherly DE, Lewis KD, Tate J, Parashar UD, Rheingans RD. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030. Vaccine 2012; 30 (Suppl 1):A7-A14.
51. Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: A systematic review and meta-analysis. Lancet Infect Dis 2012; 12:136-141.
52. Cegielski JP, Ortega YR, McKee S, Madden JF, Gaido L, Schwartz DA, et al. Cryptosporidium, enterocytozoon, and cyclospora infections in pediatric and adult patients with diarrhea in Tanzania. Clin Infect Dis 1999; 28:314-321.
53. Tumwine JK, Kekitiinwa A, Bakeera-Kitaka S, Ndeezi G, Downing R, Feng X, et al. Cryptosporidiosis and microsporidiosis in Ugandan children with persistent diarrhea with and without concurrent infection with the human immunodeficiency virus. Am J Trop Med Hygiene 2005; 73:921-925.
54. Binka E, Vermund SH, Armah GE. Rotavirus diarrhea among children less than 5 years of age in urban Ghana. Pediatric Infect Dis J 2011; 30:716-718.
55. Molbak K, Hojlyng N, Gottschau A, Sa JC, Ingholt L, da Silva AP, et al. Cryptosporidiosis in infancy and childhood mortality in Guinea Bissau, west Africa. BMJ 1993; 307:417-420.